TP53 and neoplasm: p53 and BAP1 (tumor suppressors) mutations [14, 48], increased expression of OTUB1 (tumor growth-promoting protein) [49], and loss of KRAS (proto-oncogene) [50] are associated with SLC7A11 overexpression, causing inhibition of ferroptosis and promotion of tumor growth.